Overview

Update
IPO / Stock
Went Public on Aug 13, 2008 / NASDAQ:MYRG
Total Equity Funding
$9.52M in 2 Rounds from 2 Investors
Headquarters:
Rolling Meadows, IL
Description:
MYR is a biotechnology company developing drugs for the treatment of chronic hepatitis B and D infections.
Categories:
Biotechnology
Website:
http://www.myrgroup.com/

Funding Rounds (2) - $9.52M

Update
DateAmount / RoundValuationLead InvestorInvestors
Oct, 2014€7M / Venture2
May, 2011€500k / Venture1

Investors (2)

Current Team (2)

Update

News (1)

Update
DateNews
May 12, 2011FinSMEs - FinSMEs

Offices/Locations (1)

Update
  • Headquarters

    1701 Golf Road

    Suite 3-1012

    Rolling Meadows, IL 60008-4270

    USA

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos